ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Publication in Bloomberg Law: ‘A Third J&J Bankruptcy Attempt Won’t Resolve Victims’ Talc Claims’ by Andy Birchfield

In a compelling new article published in Bloomberg Law, attorney Andy Birchfield, who leads the mass torts section at the Beasley Allen Law Firm, delves into the ongoing struggle for justice in the face of mounting evidence linking Johnson & Johnson's (NYSE: JNJ) talc products to devastating health issues, particularly ovarian cancer and mesothelioma. Birchfield, an advocate for consumers harmed by defective products, passionately outlines the challenges and responsibilities of representing thousands of victims in their quest for justice.

This article highlights the profound pain and suffering endured by victims and their families, emphasizing the urgent need for accountability in cases involving tainted talc products. Dozens of peer-reviewed scientific studies have reinforced the connection between talc usage and these debilitating diseases, with the presence in talc of asbestos, a known carcinogen, raising alarming concerns.

Rather than acknowledging the scientific evidence and providing equitable compensation to victims, Birchfield argues that Johnson & Johnson has resorted to evasive tactics and legal maneuvering. The article underscores the company's controversial "Texas Two-Step" bankruptcy strategy, a strategy recently struck down by a federal appeals court and which Birchfield describes as a disservice both to the victims and J&J shareholders.

Birchfield emphasizes that the potential success of J&J's bankruptcy scheme would have been a grave miscarriage of justice, depriving victims of their rightful day in court and offering inadequate compensation. He characterizes J&J's strategy as a gamble on perceived weaknesses within the multidistrict litigation system and a blatant attempt to halt the wheels of justice.

Birchfield also sheds light on J&J's unwillingness to negotiate in good faith if it retains the threat of bankruptcy, which previously halted jury trials. He emphasizes that bankruptcy, designed to aid struggling businesses seeking a fresh start, has been weaponized by profitable corporations such as J&J to evade responsibility, bypassing the checks and balances of the jury trial system.

In response to the ongoing legal battle involving Johnson & Johnson's talc products, Jason Itkin at the law firm Arnold & Itkin expressed his opposition to J&J’s bankruptcy strategy, stating, "J&J improperly sought to use bankruptcy as a weapon to delay and diminish my clients’ rights. I look forward to exposing J&J’s conduct and getting full justice for these cancer victims by trying their cases to judges and juries across the country."

Additionally, Mike Papantonio, a stalwart of civil justice and the leader of some of the largest mass torts in history, remarked, "The repeated bankruptcy filings by Johnson & Johnson are nothing less than a blatant flaunting of the rule of law and demonstrate the thuggish mentality of the corporate giant."

In light of J&J signaling a third bankruptcy filing, Birchfield calls for a united front to refuse further negotiations within the bankruptcy arena. He advocates for a renewed commitment to a just and equitable resolution outside of bankruptcy, emphasizing the importance of holding corporations accountable for the impact of their products on individuals and families.

These quotes from legal experts highlight the growing concerns within the legal community regarding Johnson & Johnson's handling of the talc-related litigation. The battle for justice for talc victims continues amid the company's bankruptcy strategies.

In closing his commentary, Birchfield reaffirms his unwavering dedication to seeking justice for victims and their families, asserting that the principles of our civil justice system demand nothing less.

About the Author: Andy Birchfield is a distinguished attorney managing mass torts at the Beasley Allen Law Firm, with a specific focus on pharmaceutical litigation, including representing talc claimants against Johnson & Johnson.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.43
+1.08 (0.48%)
AAPL  270.97
-2.70 (-0.99%)
AMD  214.95
+1.52 (0.71%)
BAC  55.88
+0.61 (1.10%)
GOOG  311.33
+2.72 (0.88%)
META  661.50
+2.73 (0.41%)
MSFT  484.92
-1.00 (-0.21%)
NVDA  183.69
+2.70 (1.49%)
ORCL  198.38
+6.41 (3.34%)
TSLA  488.73
+7.53 (1.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.